Slow study start-ups tied to local IRB use, expert says
WCG’s Chief Medical Officer and President of Consulting Services, Lindsay McNair, MD, MPH, MSBioethics, discusses time savings associated with the study start-up process in an interview with Outsourcing-Pharma.com’s editor, Zachary Brennan.
Publication: Outsourcing-Pharma.com
To read the article, click here.